Wieringa, G., Queralto, J., Homšak, E., Jassam, N., Cavalier, E., Svinarov, D., Krleža, J., Christou, S., Pikner, R., Larsen, T., Tomberg, K., Linko-Parvinen, A., Sapin, V., Baum, H., Kroupis, C., Bagoly, Z., Costelloe, S., Sciacovelli, L., Stasulans, J., Vitkus, D., Meunier, D., Solnica, B., Reguengo, H., Mambet, C., Kovac, G., Krhin, B., Ohlson, M., Buhagiar, G., Simundic, A.: A proposed common training framework for specialists in laboratory medicine under EU directive 2013/55/EC (The recognition of professional qualifications).
Clin. Chem. Lab. Med. 59 (3), 505-512, 2021.

Lóczi, L., Kappelmayer, J., Tarr, T., Bagoly, Z.: Antiphospholipid syndrome and the risk of myocardial infarction: current evidence and uncertainties.
Kardiol. Pol. 78 (1), 6-14, 2020.

Santoso, C., Bramantoro, T., Nguyen, M., Bagoly, Z., Nagy, A.: Factors Affecting Dental Service Utilisation in Indonesia: a Population-Based Multilevel Analysis.
Int. J. Environ. Res. Public Health. 17 (15), 1-11, 2020.

Hajas, O., Bagoly, Z., Tóth, N., Urbancsek, R., Kiss, A., Kovács, K., Sarkady, F., Nagy, A., Oláh, A., Nagy, L., Clemens, M., Csiba, L., Csanádi, Z.: Intracardiac Fibrinolysis and Endothelium Activation Related to Atrial Fibrillation Ablation with Different Techniques.
Cardiol Res Pract. 2020 1-8, 2020.

Laczkóné Majer, R., Adeyi, O., Bagoly, Z., Simon, V., Csiba, L., Kardos, L., Hortobágyi, T., Frecska, E.: Neuropsychiatric symptoms, quality of life and caregivers' burden in dementia.
Open Med. 15 (1), 905-914, 2020.

Zabczyk, M., Natorska, J., Bagoly, Z., Sarkady, F., Baráth, B., Katona, É., Bryk, A., Zettl, K., Wisniewski, J., Undas, A.: Plasma fibrin clots of pulmonary embolism patients present increased amounts of factor XIII and alpha2-antiplasmin at 3 months' anticoagulation since the acute phase.
J. Physiol. Pharmacol. 71 (4), 519-524, 2020.

Bryk, A., Siudut, J., Broniatowska, E., Bagoly, Z., Baráth, B., Katona, É., Undas, A.: Sex-specific alteration to <U+00af>2-antiplasmin incorporation in patients with type 2 diabetes.
Thromb. Res. 185 88-62, 2020.

Szegedi, I., Orbán-Kálmándi, R., Csiba, L., Bagoly, Z.: Stroke as a Potential Complication of COVID-19-Associated Coagulopathy: a Narrative and Systematic Review of the Literature.
J Clin Med. 9 (10), 3137-3148, 2020.

Kattula, S., Bagoly, Z., Tóth, N., Muszbek, L., Wolberg, A.: The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations.
J. Thromb. Haemost. 18 (4), 885-894, 2020.

Bagoly, Z., Hajas, O., Urbancsek, R., Kiss, A., Fiak, E., Sarkady, F., Tóth, N., Orbán-Kálmándi, R., Kovács, K., Nagy, L., Nagy, A., Kappelmayer, J., Csiba, L., Csanádi, Z.: Uninterrupted Dabigatran Administration Provides Greater Inhibition against Intracardiac Activation of Hemostasis as Compared to Vitamin K Antagonists during Cryoballoon Catheter Ablation of Atrial Fibrillation.
J Clin Med. 9 (9), 1-13, 2020.

Orosz, A., Csapó, A., Bagoly, Z., Székely, E., Tóth, E., Kovács, B., Bereczky, Z., Muszbek, L., Katona, É.: A new ELISA method for the measurement of total <U+00af>2-plasmin inhibitor level in human body fluids.
J. Immunol. Methods. 471 27-33, 2019.

Bagoly, Z., Muszbek, L.: Factor XIII: what does it look like?.
J. Thromb. Haemost. 17 (5), 714-716, 2019.

Árokszállási, T., Bagoly, Z., Fekete, K., Fekete, I., Szegedi, I., Andrejkovics, M., Tóth, J., Csiba, L.: Hemostasis biomarkers in the prognosis of non-traumatic intracerebral hemorrhage.
Eur. Stroke J. 4 (Suppl.), 449, 2019.

Bereczky, Z., Balogh, L., Bagoly, Z.: Inherited thrombophilia and the risk of myocardial infarction: current evidence and uncertainties.
Kardiol. Pol. 77 (4), 419-429, 2019.

Bagoly, Z., Szegedi, I., Orbán-Kálmándi, R., Tóth, N., Csiba, L.: Markers of Coagulation and Fibrinolysis Predicting the Outcome of Acute Ischemic Stroke Thrombolysis Treatment: a Review of the Literature.
Front. Neurol. 10 1-13, 2019.

Szegedi, I., Nagy, A., Székely, E., Czuriga-Kovács, K., Sarkady, F., Lánczi, L., Berényi, E., Csiba, L., Bagoly, Z.: PAI-1 5G/5G genotype is an independent risk of intracranial hemorrhage in post-lysis stroke patients.
Ann. Clin. Trans. Neurol. 6 (11), 2240-2250, 2019.

Szegedi, I., Árokszállási, T., Fekete, I., Fekete, K., Nagy, A., Sarkady, F., Székely, E., Czuriga-Kovács, K., Berényi, E., Bagoly, Z., Csiba, L.: The association of plasminogen activator inhibitor-1 (pai-1) 4g/5g polymorphism with the risk and prognosis of intracerebral hemorrhage.
Eur. Stroke J. 4 (Suppl.), 470, 2019.

Orbán-Kálmándi, R., Szegedi, I., Fekete, I., Fekete, K., Sarkady, F., Varga, L., Csiba, L., Bagoly, Z.: The use of ex vivo clot lysis assay for predicting outcomes in acute ischemic stroke patients who underwent intravenous thrombolysis.
Eur. Stroke J. 4 (Suppl.), 742-743, 2019.

Bagoly, Z.: Altered fibrin clot phenotype as predictor of the risk of recurrent venous thromboembolism: evidence is growing.
Pol. Arch. Intern. Med. 128 (10), 569-571, 2018.

Tóth, N., Székely, E., Czuriga-Kovács, K., Sarkady, F., Nagy, O., Lánczi, L., Berényi, E., Fekete, K., Fekete, I., Csiba, L., Bagoly, Z.: Elevated factor VIII and von Willebrand factor levels predict unfavorable outcome in stroke patients treated with intravenous thrombolysis.
Front. Neurol. 8 1-10, 2018.

Baráth, B., Bagoly, Z., Szegedi, I., Orbán-Kálmándi, R., Csiba, L., Katona, É.: Incorporation of Alpha-2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients Receiving Thrombolytic Therapy.
Proceedings. 2 (9), 101-102, 2018.

Székely, E., Czuriga-Kovács, K., Bereczky, Z., Katona, É., Mezei, Z., Nagy, A., Tóth, N., Berényi, E., Muszbek, L., Csiba, L., Bagoly, Z.: Low factor XIII levels after intravenous thrombolysis predict short-term mortality in ischemic stroke patients.
Sci. Rep. 8 (1), 1-9, 2018.

Gindele, R., Colombo, R., Szabó, Z., Speker, M., Mezei, Z., Balogh, L., Katona, É., Bagoly, Z., Fiatal, S., Bereczky, Z.: Prevalence of Antithrombin Budapest 3 Mutation among Different Patients Groups; Investigation of the Age and Origin of Mutation Common in Hungary.
Proceedings. 2 (9), 76-77, 2018.

Bagoly, Z., Baráth, B., Szegedi, I., Orbán-Kálmándi, R., Csiba, L., Katona, É.: The Effect of Factor XIII Levels on the Incorporation of [alfa]2-plasmin Inhibitor into Fibrin Clots: association with the Therapeutic Outcome of Acute Ischemic Stroke Patients.
Res. Pract. Thromb. Haemost. 2 198-198, 2018.

Bagoly, Z., Ariens, R., Rijken, D., Pieters, M., Wolberg, A.: Clot Structure and Fibrinolysis in Thrombosis and Hemostasis.
Biomed Res. Int. 2017 1-2, 2017.

Tóth, N., Csanádi, Z., Hajas, O., Kiss, A., Nagy-Baló, E., Kovács, K., Sarkady, F., Muszbek, L., Bereczky, Z., Csiba, L., Bagoly, Z.: Intracardiac hemostasis and fibrinolysis parameters in patients with atrial fibrillation.
Biomed Res. Int. 2017 (3678017), 1-10, 2017.

Hudák, R., Székely, E., Czuriga-Kovács, K., Nagy, A., Hofgárt, G., Berényi, E., Csiba, L., Kappelmayer, J., Bagoly, Z.: Low thrombin generation predicts poor prognosis in ischemic stroke patients after thrombolysis.
PLoS One. 12 (7), 1-13, 2017.

Bagoly, Z.: Uncovering the genetic background of natural anticoagulant deficiencies: time to look behind the scenes.
Pol. Arch. Med. Wewn. 127 (7-8), 465-467, 2017.

Bagoly, Z., Homoródi, N., Kovács, E., Sarkady, F., Csiba, L., Édes, I., Muszbek, L.: How to test the effect of aspirin and clopidogrel in patients on dual antiplatelet therapy?.
Platelets. 27 (1), 59-65, 2016.

Csomós, K., Kristóf, E., Márkus, B., Csomós, I., Kovács, G., Rotem, O., Hodrea, J., Bagoly, Z., Muszbek, L., Balajthy, Z., Csősz, É., Fésüs, L.: Protein cross-linking by chlorinated polyamines and transglutamylation stabilizes neutrophil extracellular traps.
Cell Death Dis. 7 (8), e2332, 2016.

Mezei, Z., Katona, É., Kállai, J., Bereczky, Z., Molnár, É., Kovács, B., Ajzner, É., Bagoly, Z., Miklós, T., Muszbek, L.: Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism.
Thromb. Res. 148 101-106, 2016.

Bagoly, Z.: Cancer and thrombosis: a fresh look at an old story.
Thromb. Res. 136 1-2, 2015.

Csanádi, Z., Kiss, A., Tóth, N., Bagoly, Z., Bereczky, Z., Muszbek, L., Csiba, L.: Haemostasis changes and endothelium activation during percutaneous transcatheter isolation of the pulmonary veins in patients with atrial fibrillation.
Can. J. Cardiol. 31 (10), S255, 2015.

Katona, É., Pénzes-Daku, K., Csapó, A., Fazakas, F., Udvardy, M., Bagoly, Z., Orosz, Z., Muszbek, L.: Interaction of factor XIII subunits.
Blood. 123 (11), 1757-1763, 2014.

Bagoly, Z., Sarkady, F., Magyar, M., Kappelmayer, J., Pongrácz, E., Csiba, L., Muszbek, L.: Comparison of a New P2Y12 Receptor Specific Platelet Aggregation Test with Other Laboratory Methods in Stroke Patients on Clopidogrel Monotherapy.
PLoS One. 8 (7), e69417, 2013.

Lahav, J., Tvito, A., Bagoly, Z., Dardik, R., Inbal, A.: Factor XIII improves platelet adhesion to fibrinogen by protein disulfide isomerase-mediated activity.
Thromb. Res. 131 (4), 338-341, 2013.

Bagoly, Z., Székely, E., Kovács, K., Mezei, Z., Katona, É., Kappelmayer, J., Csiba, L., Muszbek, L.: The effect of factor XIII and other regulators of fibrinolysis on the outcome of thrombolysis in ischemic stroke patients.
J. Thromb. Haemost. 11 (s2), 405-406, 2013.

Simon, Á., Bagoly, Z., Hevessy, Z., Csáthy, L., Katona, É., Vereb, G., Ujfalusi, A., Szerafin, L., Muszbek, L., Kappelmayer, J.: Expression of coagulation factor XIII subunit A in acute promyelocytic leukemia.
Cytom. Part B. Clin. Cytom. 82B (4), 209-216, 2012.

Bagoly, Z., Koncz, Z., Hársfalvi, J., Muszbek, L.: Factor XIII, clot structure, thrombosis.
Thromb. Res. 129 (3), 382-387, 2012.

Bagoly, Z., Katona, É., Muszbek, L.: Factor XIII and inflammatory cells.
Thromb. Res. 129 (Suppl.2), S77-S81, 2012.

Koncz, Z., Bagoly, Z., Haramura, G., Mezei, Z., Muszbek, L.: Thrombomodulin-dependent effect of factor VLeiden mutation on factor XIII activation.
Thromb. Res. 129 (4), 508-513, 2012.

Koncz, Z., Bagoly, Z., Haramura, G., Mezei, Z., Muszbek, L.: Thrombomodulin-dependent effect of factor V Leiden mutation on the cross-linking of alfa2-plasmin inhibitor to fibrin and its consequences on fibrinolysis.
Thromb. Res. 130 (3), 528-534, 2012.

Bagoly, Z.: A klinikai kutatások előfeltételeinek biztosítása.
In: A klinikai kutatások tervezése és kivitelezése : elméleti és módszertani alapok. Szerk.: Bereczky Zsuzsanna, Medicina, Budapest, 113-127, 2011.

Muszbek, L., Bereczky, Z., Bagoly, Z., Komáromi, I., Katona, É.: Factor XIII: a Coagulation Factor With Multiple Plasmatic and Cellular Functions.
Physiol. Rev. 91 (3), 931-972, 2011.

Komáromi, I., Bagoly, Z., Muszbek, L.: Factor XIII: novel structural and functional aspects.
J. Thromb. Haemost. 9 (1), 9-20, 2011.

Bagoly, Z.: Intézményen kívüli, multicentrikus és nemzetközi klinikai tanulmányok.
In: A klinikai kutatások tervezése és kivitelezése : elméleti és módszertani alapok. Szerk.: Bereczky Zsuzsanna, Medicina, Budapest, 139-147, 2011.

Bagoly, Z.: Kérdőívek tervezése, interjúk.
In: A klinikai kutatások tervezése és kivitelezése : elméleti és módszertani alapok. Szerk.: Bereczky Zsuzsanna, Medicina, Budapest, 129-137, 2011.

Muszbek, L., Bagoly, Z., Cairo, A., Peyvandi, F.: Novel aspects of factor XIII deficiency.
Curr. Opin. Hematol. 18 (5), 366-372, 2011.

Muszbek, L., Bereczky, Z., Bagoly, Z., Shemirani, A., Katona, É.: Factor XIII and Atherothrombotic Diseases.
Semin. Thromb. Hemost. 36 (1), 018-033, 2010.

Bagoly, Z., Fazakas, F., Marosi, A., Török, O., Bereczky, Z., Haramura, G., Tóth, J., Kappelmayer, J., Muszbek, L.: Variant type Glanzmann thrombasthenia caused by homozygous p.724R>X mutation in beta3 integrin.
Thromb. Res. 125 (5), 427-431, 2010.

Nagy, B., Simon, Z., Bagoly, Z., Muszbek, L., Kappelmayer, J.: Binding of plasma factor XIII to thrombin-receptor activated human platelets.
Thromb. Haemost. 102 (1), 83-89, 2009.

Lahav, J., Karniel, E., Bagoly, Z., Sheptovitsky, V., Dardik, R., Inbal, A.: Coagulation factor XIII serves as protein disulfide isomerase.
Thromb. Haemost. 101 (5), 840-844, 2009.

Mendelboum Raviv, S., Horváth, A., Aradi, J., Bagoly, Z., Fazakas, F., Batta, Z., Muszbek, L., Hársfalvi, J.: 4-thio-deoxyuridylate modified thrombin aptamer and its inhibitory effect on fibrin clot formation, platelet aggregation and thrombus growrth on subendothelial matrix.
J. Thromb. Haemost. 6 (10), 1764-1771, 2008.

Bagoly, Z., Fazakas, F., Komáromi, I., Haramura, G., Tóth, E., Muszbek, L.: Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
Thromb. Haemost. 99 668-674, 2008.

Muszbek, L., Bagoly, Z., Bereczky, Z., Katona, É.: The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis.
Cardiovasc. Hematol. Agents. Med. Chem. 6 190-205, 2008.

Bagoly, Z., Haramura, G., Muszbek, L.: Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot.
Thromb Haemost. 98 (2), 359-367, 2007.

Muszbek, L., Bagoly, Z.: Fibrin formation disorders and pregnancy loss.
Thromb. Res. Suppl. 119 (Suppl.), S69-S70, 2007.

Shemirani, A., Haramura, G., Bagoly, Z., Muszbek, L.: The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma.
Biochim. Biophys. Acta. Proteins Proteom. 1764 (8), 1420-1423, 2006.

Márián, T., Németh, E., Péli-Szabó, J., Mikecz, P., Szentmiklósi, J., Bagoly, Z., Balkay, L., Trón, L., Krasznai, Z.: Development and primary evaluation of [11C]ISC a tracer for in vivo mapping adenosine A2A receptors by PET.
Eur. J. Nucl. Med. Mol. Imaging. 32 (Suppl1), S187, 2005.

Piccardoni, P., Manarini, S., Federico, L., Bagoly, Z., Pecce, R., Martelli, N., Piccoli, A., Totani, L., Cerletti, C., Evangelista, V.: SRC-dependent outside-in signalling is a key step in the process of autoregulation of beta2 integrins in polymorphonuclear cells.
Biochem. J. 380 (Pt), 57-65, 2004.